date,title,source
Oct-24-18,Neurotrope Presents Updated Phase 2 Data of Bryostatin-1 in Moderate to Severe Alzheimer's Disease at the 11th Edition of CTAD,PR Newswire
Nov-19-18,"Report: Developing Opportunities within Command Center, Neurotrope, Selecta Biosciences, InVivo Therapeutics, SeaSpine, and Senestech  Future Expectations, Projections Moving into 2018",GlobeNewswire
Dec-17-18,Neurotrope Announces the Appointment of Two New Board Members,PR Newswire
Dec-17-18,Neurotrope Announces Publication of Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease in the Journal of Alzheimer's Disease,PR Newswire
Dec-17-18,Neurotrope Announces $22.5 Million Registered Direct Offering,PR Newswire
Jan-03-19,Neurotrope to Participate in the Sachs Associates 2nd Annual Neuroscience Innovation Forum,PR Newswire
Feb-04-19,Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with the National Cancer Institute,PR Newswire
Feb-08-19,Neurotrope to Participate in the BIO CEO & Investor Conference,PR Newswire
